This study was designed to test the effects of pentagastrin and epidermal growth factor (EGF) on stress-induced ulceration and on the antral content of gastrin and somatostatin (SLI) in rats. Four groups of 14 to 15 rats had been prepared for 7 days by one of the following methods: saline injection (control); injection of pentagastrin (250 jg/kg, 3 times/day); injection of EGF (10 jug/kg, 3 times/day); or injection of EGF plus pentagastrin. At the end of the treatment period, half of each group of rats were sacrificed (nonstress group). There were no ulcers in the nonstress control groups of rats. Stress was applied by water immersion in the remaining half of the rats. The injections of pentagastrin and/or EGF resulted in substantial increase in antral content of SLI. After 20 hours of stress, the ulcer index was 40.5 ± 3.3 in the controls, compared to 6.4 ± 1.2 and 16.2 ± 2.3 in rats that received pentagastrin or EGF, respectively. Injections of both pentagastrin and EGF resulted in an ulcer index of 26.2 ± 2.0, which was significantly lower than that in controls, but higher than that in rats treated with either peptide alone. The stress resulted in significant decrease in antral SLI in all groups of rats, whereas SLI content in rats treated with pentagastrin and/or EGF remained significantly higher than that of controls. Antral content of gastrin did not differ significantly in the four groups tested. The ulcer index was inversely correlated with antral SLI content. We confirm and extend previous observations that pentagastrin and EGF prevent stress ulcer formation, and
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Before a study, rats were fasted for 24 hours with free access to water, and then half of each group of rats were sacrificed by decapitation (nonstress control). The remaining half of rats were restrained in cylindrical plastic stress cages. Immobilized rats were immersed in a water bath at 23 C to the level of xiphoid process, for 20 hours, according to the method of Takagi and Okabe.'3 Rats were then decapitated. Blood samples were collected for serum gastrin determinations. The stomach was removed through a midline incision, inflated with 10 ml of cold saline (in order to stretch and fix mucosal folds to the same extent), and opened along the greater curvature. The antrum was immediately separated from the oxyntic gland area, subdivided into two parts, and frozen on dry ice. The stomach was examined for lesions under a dissecting microscope by an examiner who did not know the treatment regimen for that stomach. The length of each lesion was measured in millimeters and the lengths of all ulcers were added. The total length of all the lesions in millimeters was expressed as the ulcer index.
Tissue Extraction
Specimens of total antral tissue were weighed while frozen and then boiled either in distilled water or acetic acid. Tissue extraction was done by mincing one-half of the antrum and boiling it in water (10 mg/ml) for 30 minutes; the supernatants were kept frozen for measurement of gastrin by radioimmunoassay. The other half of the tissue specimen was boiled in 0.2 M acetic acid (10 mg/ml) for 15 minutes and homogenized with a tissue grinder (Kontes size AA, T. M. Kontes, Vineland, NY). The homogenate was centrifuged (10,000 g for 10 minutes) and the clear supernatant was kept frozen at -40 C until the radioimmunoassay for somatostatin was done. Just before assay, the extracts were neutralized with 0.2 M NaOH to pH 7.5, and then duplicate samples were assayed in three dilutions. When the results differed by more than 10%, the samples were reassayed.
Radioimmunoassay
Gastrin concentrations in serum and tissue extracts were measured by a specific double-antibody radioimmunoassay (the antibody used recognized all known molecular forms of gastrin).' 4 Somatostatin-like immunoreactivity (SLI) was measured by a radioimmunoassay technique that used antiserum R-101, obtained from A. Arimura (Tulane University School of Medicine, New Orleans, LA).
Synthetic Tyr-1-somatostatin (Peninsula Laboratories Inc., San Carlos, CA) was radioiodinated at room temperature (25 C), by means of the chloramine-T method. Tyr-1-somatostatin, dissolved in 0.01 M acetic acid (1 ,ug/10 ,ul), was mixed with 20 ul of 0.5 M phosphate buffer, pH 7.4, 1.0 mCi Na'25I, and chloramine-T (5 Mg in 10 ul H20) for 15 seconds. Then, 100 Ml of bovine serum albumin (10% w/v in 0.05 M phosphate buffer, pH 7.4) was added to stop the reaction. In order to remove unreacted iodine, the reaction mixture, supplemented with 1.0 ml of human outdated plasma, was shaken briefly with 20 mg QUSO G 32 (Philadelphia Quartz Co., Philadelphia, PA). After centrifugation, the pellet was washed twice with 1.0 ml of distilled water. The labeled somatostatin that had been absorbed was eluted with acetone/acetic acid/water (39:10:40) by the method of McIntosh and colleagues."5 Before assay, the tracer was repurified on a CM cellulose (CM 52) column (1 X 5 cm), with 0.002 M ammonium acetate, pH 4.6, as starting buffer, and 0.2 M ammonium acetate, pH 4.5, used for elution of the label.
Fractions from the descending slope of the second radioactive peak gave a specific activity of MCi/,ug. The maximum binding of label to excess of antiserum was between 82% and 89%, and the label was stable for 6-8 weeks at -40 C. Ion-exchange chromatography was reproducible, although the first radioactive peak showed an increase over a 2-month period. Nonspecific binding was less than 5% in most radioiodinations.
Antiserum R-101, directed towards positions 5 Fig. 1 .)
The The water-immersion stress produced linear ulcers of various length, and punctuate ulcers in the oxyntic gland area (Fig. 2) significantly higher than that of controls. Antral SLI in rats (Group 4), however, was substantially lower than that in rats treated with pentagastrin alone (Group 2).
Discussion
The results of this study demonstrated that chronic treatment with pentagastrin and EGF reduced the gastric ulcer formation that would be expected upon waterimmersion stress in rats, although pentagastrin and EGF did not differ significantly in their antiulcer activities. In the rats that received both pentagastrin and EGF, the ulcer index was higher than that in rats treated with either pentagastrin or EGF alone, which indicates that the protective actions of each agent are not additive. Since injections of pentagastrin and EGF had been completed 8 hours prior to exposure to stress, their transient effects on gastric acid secretion' may not directly account for these antiulcer activities.
Takeuchi and Johnson2 observed that chronic injection of pentagastrin prevented stress ulcer formation in rats and demonstrated that the formation of ulcers was correlated with decreases in mucosal DNA synthesis.
EGF has been shown to have a similar structure and similar biologic activities to human urogastrone, with equipotential inhibition of gastric acid secretion.'7 EGF has also been shown by Konturek and (Fig. 3) . This correlation indicates that a reduction in tissue content of somatostatin may be associated with greater susceptibility to stress ulcer.
Indeed, the role of somatostatin in the pathophysiology of gastric and duodenal ulcers has been the subject of many studies. Schwille8 and Zierden7 and their colleagues observed that exogenous somatostatin prevented the formation of stress ulcers in rat gastric mucosa in a dose-dependent manner. The significance of gastric somatostatin seems to be more apparent in clinical studies on duodenal ulceration. Chayvialle and colleagues'0 showed, for example, that duodenal ulceration is associated with a reduction of somatostatin in the antrum, and Sumii and colleagues20 observed a substantial decrease Hiraishi and colleagues26 demonstrated that EGF stimulated prostaglandin synthesis in rat gastric mucosal cells. We measured only antral SLI content, but we should note that somatostatin might act on the gastric fundus in both a paracrine and an endocrine manner.
The mechanism by which both pentagastrin and EGF increased SLI content in the rat antrum is difficult to explain. Chiba and colleagues27 studied the effects of various peptides on the release of somatostatin from the isolated rat stomach. In their study, secretin evoked the greatest release of somatostatin, whereas the effect of pentagastrin on somatostatin release was found to be less remarkable. Plasma somatostatin is also increased by acidification of the antral mucosa.28 Pentagastrin, therefore, appears to stimulate somatostatin in a direct manner by stimulation of D cells, and in an indirect one by inducing gastric acid secretion. The latter mechanism may enhance secretin release, with subsequent release of antral somatostatin.
The effect of EGF on release of somatostatin is not known. Unpublished preliminary studies in our laboratory indicated that infusion of graded doses of EGF into the gastroepiploic artery in dogs results in a dosedependent release of somatostatin into the gastric vein. Hence, it is possible that continuous stimulation of the release of somatostatin, evoked by pentagastrin or EGF, may result in increase in antral somatostatin content, as ACTH stimulates the content of corticosterone in the rat adrenal gland. 29 The exact chain of events, however, that leads to higher antral somatostatin concentrations in response to pentagastrin and EGF is not known.
In conclusion, chronic injection of pentagastrin and EGF resulted in increase in resistance to stress-induced ulceration in rats. Although pentagastrin and EGF may prevent stress ulcer by means of their trophic action on gastric mucosa, the significant relationship between ulcer index and antral content of somatostatin suggests that endogenous somatostatin may be involved in prevention of stress ulcer formation.
